Andrew Hykes Inari Medical, Inc. (NARI) insider trading activity

Andrew Hykes is President and CEO of Inari Medical, Inc.. Currently has a direct ownership of 439,310 shares of NARI, which is worth approximately $23.6 Million. The most recent transaction as insider was on Dec 20, 2024, when has been sold 3,000 shares (Common Stock) at a price of $55.43 per share, resulting in proceeds of $166,290. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 439K

2.92% 3M change

1.03% 12M change

Total Value Held $23.6 Million

Andrew Hykes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 20 2024	SELL Open market or private sale	$166,290 $55.43 p/Share	3,000 Reduced 0.68%	439,310 Common Stock
Nov 20 2024	SELL Open market or private sale	$152,490 $50.83 p/Share	3,000 Reduced 0.67%	442,310 Common Stock
Oct 29 2024	SELL Open market or private sale	$150,000 $50.0 p/Share	3,000 Reduced 0.67%	445,310 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$171,539 $40.63 p/Share	4,222 Reduced 0.93%	448,310 Common Stock
Aug 20 2024	SELL Open market or private sale	$150,000 $50.0 p/Share	3,000 Reduced 0.66%	452,532 Common Stock
Jul 22 2024	SELL Open market or private sale	$165,690 $55.23 p/Share	3,000 Reduced 0.65%	455,252 Common Stock
Jul 01 2024	SELL Open market or private sale	$150,240 $50.08 p/Share	3,000 Reduced 0.64%	462,474 Common Stock
Jul 01 2024	SELL Payment of exercise price or tax liability	$211,902 $50.19 p/Share	4,222 Reduced 0.91%	458,252 Common Stock
May 28 2024	SELL Open market or private sale	$150,000 $50.0 p/Share	3,000 Reduced 0.64%	465,474 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	-	4,222 Reduced 0.89%	468,474 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	40,786 Added 7.94%	472,696 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$198,849 $64.92 p/Share	3,063 Reduced 0.7%	431,754 Common Stock
Nov 16 2023	SELL Open market or private sale	$2,242,011 $59.87 p/Share	37,448 Reduced 7.93%	434,817 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$187,501 $65.4 p/Share	2,867 Reduced 0.6%	472,265 Common Stock
Aug 16 2023	SELL Open market or private sale	$2,447,756 $66.74 p/Share	36,676 Reduced 7.17%	475,132 Common Stock
Jul 01 2023	SELL Payment of exercise price or tax liability	$116,221 $58.14 p/Share	1,999 Reduced 0.39%	511,609 Common Stock
May 17 2023	SELL Open market or private sale	$1,298,004 $69.19 p/Share	18,760 Reduced 3.52%	513,608 Common Stock
May 16 2023	SELL Open market or private sale	$1,269,706 $70.87 p/Share	17,916 Reduced 3.26%	532,368 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$123,418 $61.74 p/Share	1,999 Reduced 0.36%	550,284 Common Stock
Mar 20 2023	SELL Open market or private sale	$580,140 $64.46 p/Share	9,000 Reduced 1.6%	552,283 Common Stock
Mar 12 2023	BUY Exercise of conversion of derivative security	-	430,517 Added 43.42%	561,112 Common Stock
Feb 21 2023	SELL Open market or private sale	$496,710 $55.19 p/Share	9,000 Reduced 6.45%	130,595 Common Stock
Feb 18 2023	BUY Grant, award, or other acquisition	-	46,549 Added 25.01%	139,595 Common Stock
Jan 20 2023	SELL Open market or private sale	$558,090 $62.01 p/Share	9,000 Reduced 8.82%	93,046 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$72,776 $63.56 p/Share	1,145 Reduced 1.11%	101,853 Common Stock

Andrew Hykes

President and CEO

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NARI shares.

Notify only if

Value

Insider Trading

Get notified when an Inari Medical, Inc. insider buys or sells NARI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Inari Medical, Inc.

Track Activities on NARI

Account